Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
NCT01185418 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2010-08-20
Summary
The aim of the study is to investigate the negative symptoms and cognitive function after administration of antipsychotics in healthy volunteer.
Conditions
- Normal Volunteers
Interventions
- DRUG
-
risperidone
- DRUG
-
aripiprazole
- DRUG
-
haloperidol
- DRUG
-
amisulpride
- DRUG
-
lactose
Sponsors & Collaborators
-
Chonbuk National University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 38 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
NCT00253123 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
NCT00034762 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
NCT00253110 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT00036114 ·Status: COMPLETED ·Phase: PHASE3
-
Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
NCT01105481 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
NCT00545467 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
NCT03557931 ·Status: COMPLETED ·Phase: PHASE2
-
Different Safety Profile of Risperidone and Paliperidone Extended-release
NCT01284959 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
NCT01149655 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
NCT02019329 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
NCT03839251 ·Status: COMPLETED ·Phase: PHASE4
-
Effect on Cognitive Function of a Treatment With Aripiprazole
NCT00329810 ·Status: COMPLETED ·Phase: PHASE4
-
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
NCT03883204 ·Status: UNKNOWN ·Phase: PHASE4
-
A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT01942161 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
NCT02137993 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
NCT02431702 ·Status: COMPLETED ·Phase: PHASE3
-
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
NCT01234454 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients
NCT01109147 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT01942148 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia
NCT01541371 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
NCT00249119 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia
NCT01623713 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning
NCT01161277 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Ziprasidone for Patients With Schizophrenia
NCT01198353 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
NCT01051531 ·Status: COMPLETED ·Phase: PHASE3